Side-by-side comparison of AI visibility scores, market position, and capabilities
Tarrytown NY biopharma giant; creator of Dupixent (>$14B revenue), Eylea, and Kevzara. Velocity Genome platform drives fast antibody and bispecific drug discovery.
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized mouse technology that dramatically accelerates the discovery of human antibodies—and has used it to produce multiple best-in-class biologics across inflammatory, oncologic, and eye diseases.\n\nRegeneron's commercial portfolio is anchored by Dupixent (dupilumab), developed with Sanofi, which has become one of the best-selling drugs globally with over $14 billion in 2024 revenues, treating atopic dermatitis, asthma, COPD, and other type-2 inflammatory conditions. Additional key products include Eylea (aflibercept) for macular degeneration and PRALUENT for cardiovascular cholesterol lowering. The company's bispecific antibody pipeline, cancer vaccines in collaboration with BioNTech, and gene therapy programs represent its next growth wave.\n\nRegeneron reported over $14 billion in annual revenue in 2024 and maintains a world-class science culture, consistently ranking among the top companies for R&D productivity and employee satisfaction. Its Tarrytown campus houses more than 10,000 employees and remains a leading independent US biopharmaceutical innovator.
Agriculture sustainability leader. 8M+ enrolled acres. 12-year Microsoft deal for 2.85M tonnes of carbon removal credits. $40M paid to farmers. Founded 2013, Boston.
Indigo is an agriculture sustainability company founded in 2014 and headquartered in Boston, Massachusetts, working at the intersection of agricultural productivity, environmental stewardship, and carbon markets. The company was built on the thesis that transforming farming practices at scale could simultaneously improve farmer economics and generate measurable environmental outcomes — most notably carbon sequestration through soil health improvements.\n\nIndigo's platform connects farmers with sustainability programs, market access tools, and agronomic guidance designed to support the transition to more regenerative practices. The company has enrolled more than 8 million acres in its programs and has paid $40 million directly to farmers participating in its carbon and sustainability initiatives. A landmark 12-year partnership with Microsoft covers the removal of 2.85 million tonnes of carbon, providing long-term contractual certainty for both the carbon supply chain and the farmers who generate those credits.\n\nIndigo has established itself as one of the most significant players in agricultural carbon markets, a sector whose importance has grown as corporations face pressure to meet net-zero commitments and regulators begin formalizing carbon accounting standards. The Microsoft deal's scale and duration reflects the maturation of agricultural carbon as an investable asset class. With over a decade of operating history, deep farmer relationships, and a proven model for carbon credit origination, Indigo occupies a defensible position in a market where trust, data quality, and acreage scale are the primary competitive moats.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.